Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
Aaa, administering, aforementioned, allied, arose, Asia, assigned, auction, Avecia, batch, BCP, beta, billion, Biomedical, Bioshield, BLA, blocker, BS, calendar, Cangene, career, chose, Chrion, Cold, colonization, commensurate, Commissioner, Conference, Council, cytokine, DARPA, denominated, deny, denying, engle, equine, eradication, EU, excluding, facilitate, FGI, fisher, Franchise, fulfillment, Genome, GlaxoSmithKline, globulin, gout, graduate, graph, Greg, halt, Harmonisation, healthy, heptavalent, herewith, ICH, idiopathic, impetigo, impracticable, interleukin, interrupt, invading, invited, Irish, isuncertain, Japanese, joint, Jolla, jurisdiction, juvenile, La, leadership, light, literature, MAA, Mann, MCE, medium, Micro, MRSA, mupirocin, nasal, newly, observed, older, outcome, pain, partly, partnership, pendency, perpetual, PharmAthene, poisoning, population, precisely, predetermined, premier, prescription, processed, prone, proven, proximity, reclassification, recovery, reform, Regeneron, reimportation, rent, repeat, responding, restore, retapamulin, reversal, rilonacept, scale, Science, secondary, shipment, side, simultaneously, sJIA, Stanford, statutory, stop, succeeded, suite, superficial, suspend, synthetic, Threat, track, Trap, traumatic, undesirable, unreasonable, unrecorded, uric, ustekinumab, venture, virtual
Removed:
abnormal, adjust, alerting, Amersham, analog, artery, assumed, Baxter, bioengineered, bleeding, bulk, Canadian, cancelable, choice, Cholestech, cholesterol, comparability, comparing, compensated, computed, consecutive, core, coronary, cyclosporine, deadly, delaying, demonstrating, discontinuation, Disposed, extension, fertility, frame, hormone, III, inhibitor, intention, internally, Isotechnika, issuable, launch, meningococcemia, Outlicense, outlook, plc, predefined, preferred, rationally, reach, requested, retire, retirement, settled, significance, software, strong, substance, suggested, summer, superseded, surviving, tied, tolerability, Underwriting, Viventia
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 Form of Share Option Agreement for 1981 Share Option Plan
- 10.2 Form of Share Option Agreement for Restricted Share Plan
- 10.2 Amendment No. 3 to Restricted Share Plan
- 10.3 1992 Directors Share Option Plan As Amended and Restated
- 10.3 Form of Share Option Agreement for 1992 Directors Share Option Plan
- 10.3 Form of Share Option Agreement for 1992 Directors Share Option Plan
- 10.4 CEO Incentive Compensation Plan
- 10.4 Bonus Compensation Plan
- 21.1 Subsidiaries of the Company
- 23.1 Consent of the Independent Registered Public Accounting Firm
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 32.2 Certification of CFO Pursuant to Section 906
- 99.1 Press Release
XOMA similar filings
Filing view
External links